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CLINICAL INVESTIGATION
Long-Term Survival and Risk of Institutionalization in
Onco-Geriatric Surgical Patients: Long-Term Results of the
PREOP Study
Monique G. Huisman, MD, PhD,* Federico Ghignone, MD,† Giampaolo Ugolini, MD, PhD,†
Grigory Sidorenkov, PhD,‡ Isacco Montroni, MD, PhD,† Antonio Vigano, MD,§
Nicola de Liguori Carino, MD,¶ Eriberto Farinella, MD,∥ Roberto Cirocchi, MD, PhD,∥
Riccardo A. Audisio, MD, PhD,** Geertruida H. de Bock, PhD,‡ and
Barbara L. van Leeuwen, MD, PhD*
OBJECTIVES: To evaluate long-term survival and institu-
tionalization in onco-geriatric surgical patients, and to ana-
lyze the association between these outcomes and a
preoperative risk score.
DESIGN: Prospective cohort study with long-term follow-up.
SETTING: International and multicenter locations.
PARTICIPANTS: Patients aged 70 years or older undergo-
ing elective surgery for a malignant solid tumor at five cen-
ters (n = 229).
MEASUREMENTS: We assessed long-term survival and
institutionalization using the Preoperative Risk Estimation
for Onco-geriatric Patients (PREOP) score, developed to
predict the 30-day risk of major complications. The PREOP
score collected data about sex, type of surgery, and the
American Society for Anesthesiologists classification, as well
as the Timed Up & Go test and the Nutritional Risk
Screening results. An overall score higher than 8 was con-
sidered abnormal.
RESULTS: We included 149 women and 80 men (median
age = 76 y; interquartile range = 8). Survival at 1, 2, and
5 years postoperatively was 84%, 77%, and 56%, respec-
tively. Moreover, survival at 1 year was worse for patients
with a PREOP risk score higher than 8 (70%) compared
with 8 or lower (91%). Of those alive at 1 year, 43 (26%)
were institutionalized, and by 2 years, almost half of the
entire cohort (46%) were institutionalized or had died. A
PREOP risk score higher than 8 was associated with
increased mortality (hazard ratio = 2.6; 95% confidence
interval [CI] = 1.7-4.0), irrespective of stage and age, but
not with being institutionalized (odds ratios = 1 y, 1.6
[95% CI = .7-3.8]; 2 y, 2.2 [95% CI = .9-5.5]).
CONCLUSION: A high PREOP score is associated with mor-
tality but not with remaining independent. Despite acceptable
survival rates, physical function may deteriorate after surgery.
It is imperative to discuss treatment goals and expectations pre-
operatively to determine if they are feasible. Using the PREOP
risk score can provide an objective measure on which to base
decisions. J Am Geriatr Soc 00:1-7, 2020.
Keywords: survival; institutionalization; postoperative
outcome; onco-geriatric patients; risk assessment
INTRODUCTION
The older population is growing worldwide and isexpected to exceed 1 billion by 2020.1 Given that solid
tumors mainly affect patients aged 65 years or older,
From the *Department of Surgery, University of Groningen, University
Medical Center Groningen, Groningen, The Netherlands; †Department of
Colorectal and General Surgery, Ospedale per gli Infermi, Faenza, Italy;
‡Department of Epidemiology, University of Groningen, University Medical
Center Groningen, Groningen, The Netherlands; §McGill Nutrition and
Performance Laboratory, McGill University, Montreal, Canada;
¶Manchester Royal Infirmary, Department of Hepato-Pancreato-Biliary
Surgery, Central Manchester University Hospitals, Manchester, UK;
∥Department of General Surgery and Surgical Oncology, University of
Perugia, Hospital of Terni, Terni, Italy; **Department of Surgery, Institute
of Clinical Sciences, Sahlgrenska University Hospital, Göteborg, Sweden;
Present address: Federico Ghignone, Giampaolo Ugolini and
Isacco Montroni, Department of Surgery, Faenza Hospital, Faenza, Italy;
Eriberto Farinella, Department of Surgery, Lister Hospital, East and North
Herts NHS Trust, Stevenage, UK;
Address correspondence to Monique G. Huisman, MD, PhD, Department
of Surgery, University of Groningen, University Medical Centre Groningen,




© 2020 The Authors
Journal of the American Geriatrics Society published by Wiley Periodicals, Inc. on behalf of The American Geriatrics Society. 0002-8614/20/$15.00
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs
License, which permits use and distribution in any medium, provided the original work is properly cited, the use is
non-commercial and no modifications or adaptations are made.
leaders in the field of geriatric oncology have recently
sought to emphasize that chronological age per se should
not be considered a contraindication to surgical treat-
ment.2-5 Nevertheless, older patients with cancer still often
receive substandard treatment compared with their younger
counterparts.6 For example, it was shown that older women
are offered surgical treatment less often for breast,7
pancreatic,8 and ovarian cancer.9
Researchers have suggested that surgical oncologists
deviate more often from standard treatment protocols in
the older population. This may be because they fear the
higher risk of troublesome postoperative outcomes or
because they lack certainty about the potential benefits to
survival and quality of life.10 However, data are lacking as
to why standard treatment is withheld from this cohort,
leaving doubt as to whether such decisions are justifiable.7-9
Most studies in onco-geriatric surgery have also been lim-
ited to focusing on short-term outcomes, despite the reality
that most patients will die outside of the immediate postop-
erative period.11,12 Additionally, long-term loss of indepen-
dence in older patients remains only partially explored, an
important omission because the preservation of preopera-
tive functional status was shown to be among the most
important patient-centered outcomes.13
Outcome prediction in onco-geriatric surgical patients
has gained research interest in recent years. Several studies
have evaluated the ability of time-saving and easy-to-
administer geriatric screening tools to predict the risk of
postoperative complications.14-16 The Preoperative Risk
Estimation for Onco-geriatric Patients (PREOP) study iden-
tified that using the Timed Up & Go (TUG) test and Nutri-
tional Risk Screening (NRS) as part of a risk score offered
easy and quick tools for predicting major 30-day postopera-
tive complications in onco-geriatric surgical patients.17
The primary aim of the current study was to provide
data on long-term survival and institutionalization after sur-
gery in onco-geriatric patients. Furthermore, we hypothe-
sized that impairments in specific geriatric domains might
be associated with impaired long-term outcomes, so we
analyzed the association between the PREOP risk score and
long-term survival and institutionalization rates. We antici-
pate that gaining a better understanding of long-term out-
comes will help improve preoperative decision making.
METHODS
Study Design and Participants
The current research concerns the long-term follow-up of
the prospective international multicenter PREOP cohort
study designed by the surgical task force of the Interna-
tional Society of Geriatric Oncology.17-19 The original aim
was to investigate the predictive ability of geriatric screen-
ing tools in terms of their 30-day postoperative outcomes
by assessing all domains recommended for geriatric assess-
ment (Supplementary Table S1 summarizes the assessed
tools). Patients aged 70 years or older who underwent elec-
tive surgery for suspected malignant solid tumors were
enrolled between September 2008 and October 2012. The
PREOP study was approved by the appropriate ethics com-
mittees and registered with the Dutch trial registry (Trial ID
NTR1567). All patients gave written informed consent in
accordance with the ethical standards of local ethics
committees.
Whereas previous analyses of the PREOP study focused
on short-term outcomes,17-19 the current research focused
on the long-term outcomes. Centers that participated in the
PREOP study were asked to collect additional postoperative
data for up to 2 years on survival and living situations.
These long-term follow-up data were collected between
January 2015 and August 2016. Patients were only
included for analysis if postoperative histology had con-
firmed a malignant tumor because we wanted the data set
to be affected by the presence of malignancy.
End Points
The primary end point in the current study was long-term
survival, as expressed by the postoperative survival rate at
Table 1. Baseline Variables of Onco-Geriatric Surgical
Patients
Variable
Current cohort Original cohort
P value(N = 229) (N = 276)
Sex, n (%)
Female 149 (65) 174 (63) .6
Male 80 (35) 102 (37)
Age, y, n (%)
70-74 83 (36) 100 (36) .998
75-79 71 (31) 89 (32)
80-84 52 (23) 60 (22)
≥85 23 (10) 27 (10)
Living situation, n (%)
Independent/Family 226 (99) 272 (99) .85
Residential care/
Nursing home
2 (1) 2 (1)
Surgery, n (%)
Minor 88 (38) 97 (35) .45
Major 141 (62) 179 (65)
Cancer site, n (%)
Breast 67 (29) 75 (27) .96
Colorectal 81 (35) 105 (38)
Gastric 15 (7) 21 (7.5)
Gynecologic 13 (6) 14 (5)
Pancreas and biliary tract 23 (10) 21 (7.5)
Remaining 8 (3) 11 (4)
Renal and bladder 9 (4) 14 (5)
Soft tissue and skin 13 (6) 15 (6)
Tumor stage, n (%)
Stage 1/2 132 (60) 158 (57) .79
Stage 3 47 (22) 65 (24)
Stage 4 40 (18) 53 (19)
PREOP risk score, n (%)
≤8 155 (68) 163 (65) .42
>8 74 (32) 89 (35)
The data compare the current cohort (five centers, 229 patients) with those
from the original PREOP study (eight centers, 276 patients). Patients had a
confirmed diagnosis of cancer.
Abbreviation: PREOP, Preoperative Risk Estimation for Onco-Geriatric
Patients.
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6 months and at 1, 2, and 5 years. The secondary end point
was the long-term institutionalization rate, as expressed by
the change in living situation at 1 and 2 years postopera-
tively. The living situation was defined as independent,
assisted living, or nursing home, and the status before and
after surgery was compared.
PREOP Risk Score
The PREOP risk score was derived by multivariable logistic
regression analysis for the occurrence of major 30-day post-
operative complications and comprises five variables. Two
are common geriatric screening tools, the TUG and the
NRS scores.17 The other three are sex, type of surgery, and
American Society for Anesthesiologists (ASA) classification.
The TUG assesses the time a patient needs to get up from a
chair, walk 3 m, turn around, walk back, and sit down
again.20 The NRS assesses recent weight loss, overall condi-
tion, and reduction of food intake.21 To calculate the
PREOP risk score, patients are assessed on these items and
scored as follows:
• Sex: female = 0; male = 3
• Type of surgery: minor = 0; major = 4
• TUG: ≤20 s = 0; >20 s = 3
• ASA: <3 = 0; ≥3 = 3
• NRS: normal = 0, impaired = 3
The area under the receiver operating characteristic
curve (AUC) indicated an optimal cutoff point of higher
than 8, with a higher PREOP risk score corresponding to a
higher risk of major complications.17 We therefore com-
pared high (>8) with low (≤8) PREOP risk scores.
Statistical Analysis
Descriptive data are reported as absolute numbers and as
percentages for categorical data. Overall survival was ana-
lyzed by survival analysis as the primary end point. Median
follow-up time was calculated by the Kaplan-Meier estimate
of potential follow-up method.22 Proportional hazards
assumptions were evaluated graphically, using log minus
log Cox regression curves. Cox regression was then used to
Table 2. Survival by Disease Stage and PREOP Risk
Score
Survival
6 mo (SE) 1 y, % (SE) 2 y, % (SE) 5 y, % (SE)
Stage
1/2 96% (2) 95 (2) 91% (3) 73 (5)
3 91% (4) 77 (6) 75 (7) 44 (8)
4 78% (7) 58 (8) 38 (8) 11 (5)
PREOP risk score
≤8 95% (2) 91 (2) 87 (3) 68 (4)
>8 84% (4) 70 (5) 56 (6) 30 (6)
Abbreviations: PREOP, Preoperative Risk Estimation for Onco-geriatric
Patients; SE, standard error.
Figure 1. Survival functions for the PREOP risk score per dis-
ease stage. (A) Patients with stage 1/2 disease. (B) Patients with
stage 3 disease. (C) Patients with stage 4 disease.
JAGS MONTH 2020-VOL. 00, NO. 00 LONG-TERM RESULTS OF THE PREOP STUDY 3
estimate hazard ratios (HRs) and 95% confidence intervals
(CIs) that were adjusted for each center. In the multivari-
able Cox regression analysis, the HR for the PREOP risk
score regarding mortality was adjusted for cancer stage,
age, and center. The AUC was calculated to assess the dis-
criminative value of the selected PREOP risk score cutoff in
the survival model. The AUC was reflected by the Harrell
C-statistic. Internal validation of the multivariable Cox
regression model was performed by bootstrapping with
500 resamples. The living situation at 1 and 2 years after
surgery was compared with that before surgery (ie, deterio-
ration to being institutionalized after surgery compared
with still living independently or improvement to indepen-
dent living after surgery). Logistic regression analysis was
used to estimate odds ratios (ORs) and 95% CIs, which
were adjusted for each center.
Missing values for the geriatric screening tools before
surgery were handled by multiple imputation after the
assumptions for performing multiple imputation were
checked and met.17,19 The PREOP risk scores were calcu-
lated based on these imputed data sets that were then used
in the current analyses. Overall, values were considered
statistically significant at P ≤ .05. Statistical analyses were
completed with IBM SPSS v.23 and Stata/SE v.14.2.
RESULTS
Description of Cohort
Of the 328 patients in the original study, 276 were eligible
for this study after excluding patients with benign patholo-
gies. However, we lost another 47 of these patients (17%)
to follow-up because only five centers agreed to collect
long-term follow-up data. Two centers were unable to col-
lect data due to a lack of clerical help, and one center did
not respond to our invitation. Thus we were left with a
final cohort of 229 patients for the present study. As
shown in Table 1, the baseline variables were comparable
between the cohorts with proven malignancy, with exclu-
sion of the three nonparticipating centers having no major
effect.
Survival
The median follow-up time was 55 months (95%
CI = 54-56 mo), and the overall postoperative survival at
.5, 1, 2, and 5 years was 91%, 84%, 77%, and 56%,
respectively. The overall survival rates by disease stage and
PREOP risk score are shown in Table 2. Disease stage
Figure 2. Living situation preoperatively and at 1 and 2 years postoperatively. *From 1 to 2 years postoperatively five patients
deteriorated, one of whom moved from assisted living to a nursing home (so not shown in flowchart).
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3 (HR = 3.1; 95% CI = 1.8-5.3) and stage 4 (HR = 6.4;
95% CI = 3.6-11.4), as well as age (HR = 1.1; 95%
CI = 1.0-1.1), were statistically significant predictors of
increased mortality. Moreover, a high PREOP risk score
(>8) remained a statistically significant predictor of
increased mortality (HR = 3.1; 95% CI = 2.0-4.7),
irrespective of disease stage and age (HR = 2.6; 95%
CI = 1.7-4.0). Despite excluding patients who did not sur-
vive the first postoperative year (seeking to eliminate the
impact of postoperative complications), the multivariable
association persisted between the PREOP risk score and
mortality (HR = 2.5; 95% CI = 1.5-4.4).
The HR for high PREOP score was similar after boot-
strap analysis corrected for disease stage and age
(HR = 2.7; 95% CI = 1.7-4.3). Bias was considered low
because the percentile CIs (1.71-4.31) and bias-corrected
CIs (1.79-4.39) were comparable. The AUC of the PREOP
risk score was .78 and showed fair discriminatory capacity.
The survival functions for the PREOP risk score are
shown by disease stage in Figure 1. The 1-year survival
rates were 70% (standard error = 5%) and 91% (standard
error = 2%) for patients with PREOP risk scores higher
than 8 and 8 or lower, respectively.
Deterioration in Living Situation
The postoperative living situations of older patients at
1 and 2 years are shown in Figure 2. A total of 43 patients
(26%) were institutionalized by the end of the first postop-
erative year, compared with 42 (27%) by the end of the sec-
ond postoperative year. When comparing these living
situations, one patient improved (.6%) and five patients
deteriorated (3%) between the first and second years. Of
the two patients who had lived in a nursing home preopera-
tively, one was able to move to an independent living situa-
tion, and the other patient did not survive the first
postoperative year.
A PREOP risk score higher than 8 was not significantly
associated statistically with a higher risk for postoperative
institutionalization at either 1 year (OR = 1.6; 95%
CI = .7-3.8) or 2 years (OR = 2.2; 95% CI = .9-5.5); by
contrast, the age, ASA classification, and TUG components
of the PREOP risk score were associated with higher risk
(Table 3). However, the proportion of patients living inde-
pendently at home did not differ with statistical significance
between patients with high and low PREOP risk scores
either at 1 year (high = 68%; low = 76%; P = .36) or at
2 years (high = 63%; low = 76%; P = .13).
DISCUSSION
The overall postoperative survival rates decreased from
91% at 6 months to 56% at 5 years, and a notable differ-
ence was found in survival rates at 1 year between patients
with PREOP risk scores higher than 8 and 8 or lower (70%
and 91%, respectively). Among the patients alive at 1 year,
1 in 4 were institutionalized, and at 2 years, almost one-half
of the entire cohort (46%) were institutionalized or had
died. Overall, the PREOP risk score was associated with
survival, irrespective of disease stage and age, but not with
the risk of institutionalization.
Short-term and long-term survival rates in our study
were comparable with those reported in other cohorts of
older patients.11,23-26 A study by Ommundsen et al is one of
only a few to have focused on long-term survival in older
patients, specifically those with colorectal cancer, and noted
a 5-year survival rate of 48%.23 As with our results, they
also noted that frailty was accompanied with decreased sur-
vival, irrespective of disease stage, reporting 5-year survival
rates of 24% in frail patients and 66% in non-frail
patients.23 Postoperative survival rates at 1 year in our
cohort were 70% and 91%, respectively. The PREOP risk
score itself was associated with the observed long-term sur-
vival. Ommundsen et al further reported that nutritional sta-
tus, instrumental activities of daily living, and comorbidities
were each predictive of long-term survival, independent of
disease stage.23 However, a systematic review produced con-
flicting results concerning survival prediction.27 In most stud-
ies, irrespective of the definitions used, frailty and
comorbidity are statistically and significantly associated with
Table 3. Association of Preoperative Variables with
Deterioration in Living Situation at 1 Yeara
Living situation
IndependentN (%) InstitutionalizedN (%) OR (95% CI)b
Age, y
70-74 46 (38) 12 (28) 1
75-79 40 (33) 10 (23) 1.7 (.5-5.6)
80-84 27 (22) 15 (35) 5.0 (1.5-16.2)
≥85 8 (7) 6 (14) 6.1 (1.5-25.5)
Sex
Female 81 (67) 32 (74) 1
Male 40 (33) 11 (26) .7 (.3-1.8)
Disease stage
1/2 85 (73) 28 (65) 1
3 21 (18) 8 (19) .9 (.3-2.7)
4 10 (9) 7 (16) 3.6 (.7-17.5)
Type of surgery
Minor 61 (50) 19 (44) 1
Major 60 (50) 24 (56) 1.1 (.5-2.6)
PREOP risk scorec
≤8 93 (77) 30 (70) 1
>8 28 (23) 13 (30) 1.6 (.7-3.8)
NRS
Normal 92 (76) 32 (74) 1
Impaired 29 (24) 11 (26) 1.1 (.4-2.9)
TUG test
≤20 112 (93) 33 (77) 1
>20 9 (7) 10 (23) 4.5 (1.5-13.4)
ASA
<3 71 (59) 16 (37) 1
≥3 50 (41) 27 (63) 3.3 (1.4-7.9)
Abbreviations: ASA, American Society for Anesthesiologists [classification];
CI, confidence interval; OR, odds ratio; NRS, Nutritional Risk Screening;
PREOP, Preoperative Risk Estimation for Onco-Geriatric Patients; TUG,
Time Up & Go.
Figures shown in boldface are statistically significant.
aBecause the deterioration in living situation occurred mainly during the
first postoperative year, results for this end point were shown.
bUnivariable OR, adjusted for center.
cPREOP risk score includes sex, type of surgery, TUG, ASA, and NRS.
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survival, whereas functional status and nutritional status are
not typically associated. The presence of frailty, whether
established by a formal assessment tool or by clinical judg-
ment, may account in other research for the numbers of
older people considered undertreated compared with youn-
ger peers.7-9
The long-term use of post-acute care services (eg, spe-
cialist nursing or long-term care facilities) is high among
older adult cancer patients undergoing surgery when com-
pared with those who have no cancer.28 By 2 years postop-
eratively in the current study, approximately 1 in 5 patients
was institutionalized, one-quarter had died, and one-half
were living independently at home. A deterioration in living
situation can be considered a proxy for functional status,29
with an increased level of dependency in both activities of
daily living and instrumental activities of daily living being
precursors to institutionalization. Although a postoperative
deterioration in functional status is frequently observed, the
prevalence varies from 3% to 69% depending on the popu-
lation under study, the type of end point, and the follow-up
duration.30-33 Although partial recovery can be observed
during the postoperative course, overall functional status
scores at 1 year rarely return to preoperative levels.31 This
deterioration occurs predominantly in older patients,33,34
especially in those who are frail.34 These results indicate
that older patients are at increased risk of permanent, or at
least long-term, functional decline after surgery.
The failure to show an association between the PREOP
risk score and the risk of institutionalization may be due to
a lack of power. A similar conclusion by Rønning et al that
frailty indicators were not predictive of functional decline
may also have been due to a lack of power.33 However, a
recent study by Williams et al of 125 older patients with
cancer showed that (pre-)frailty and impaired functional
status were associated with greater long-term care use.35
Another possible explanation for the lack of association in
our research could be that the PREOP risk score was
designed to predict clinical outcomes, whereas risk of insti-
tutionalization is determined by several other nonclinical
factors, such as the presence of a family and a patientʼs
financial situation. Moreover, cultural differences in the
international cohort might have obscured outcomes by
influencing the destinations of patients with functional
decline.36 Finally, it is possible that factors other than the
index surgery (eg, comorbidities or recurrence) led to func-
tional decline and institutionalization.
We observed associations between long-term institution-
alization and greater age, ASA classification, and TUG
scores. Other studies have reported that greater age, stage,
impairment in pretreatment functional status, and treatment
intensity, as well as the occurrence of postoperative compli-
cations, were associated with postoperative functional decline
and increased long-term care use.28,32,34,35 Functional decline
can result from a protracted postoperative course in patients
with reduced physiologic reserves at the start of their treat-
ment, and studies showed that “prehabilitation” can have a
positive effect on postoperative outcomes.37-39 This indicates
scope to improve PREOP risk scores and to reduce the risk
of adverse outcomes.
The current study has a few limitations. First, loss to
follow-up occurred because several patients died, thereby
decreasing the sample size. Although clearly inherent to this
age group, this loss to follow-up limited the number of vari-
ables that could be included in the statistical models and
precluded any meaningful stratified analysis by cancer site.
Compounding this issue, three centers that contributed to
the study of short-term outcomes did not contribute to the
present research. Fortunately, patientsʼ characteristics were
similar in both cohorts. Second, no data were obtained on
whether patients were treated with adjuvant chemotherapy,
which is important because this can improve survival and
may have affected our results. Given that long-term institu-
tionalization is a crude measure of functional decline, we
probably only included patients who deteriorated most,
which will have further underestimated the magnitude of
this problem. Nevertheless, the high prevalence of long-term
institutionalization emphasizes the importance of this out-
come measure in the onco-geriatric population. Third,
external validation of the PREOP risk score is still needed
to confirm its generalizability as a screening tool. Internal
validation has already been performed, and the results of
the bootstrap analysis in this study confirm that the
obtained HR data are valid.
In the current study, we aimed to report on the long-
term outcomes in onco-geriatric patients undergoing sur-
gery for cancer, anticipating the information could be used
to support shared decision making in routine clinical prac-
tice. It is with increasing conviction that we advise that
advancing age, in isolation, should not be considered a suf-
ficiently strong factor to justify withholding surgery with
curative intent from older patients. Indeed, our data have
shown that survival rates were rather good, with most
patients able to live independently at home, despite invasive
cancer treatments. Patients with a PREOP risk score of 8 or
lower were most likely to have an uncomplicated course by
2 years postoperatively, whereas those with higher scores
were at increased risk of a complicated postoperative
course. When treating these patients, although cure may be
possible, we should be aware that patients will not necessar-
ily return to their preoperative level of function. Indeed, it
is of utmost importance that both physicians and patients
are aware of this before surgery. Detailed discussion of the
goals and expectations of surgery is imperative, allowing us
to verify their feasibility based on individualized and objec-
tive risk assessments.
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